Minder, the iCEM system, could provide more effective diagnosis and management for people living with epilepsy. The technology also received FDA breakthrough device designation, according to a news release.

Australia-based Epiminder designed Minder to address the shortcomings in current electroencephalogram (EEG) technologies. It aims to provide reliable, actionable diagnostic data for more patients to enhance epilepsy treatment and management.

CEO Rohan Hoare says the system extends the monitoring window of EEG from days to months or even years. This could deliver “unprecedented access” to continuous EEG data for both healthcare professionals and their patients